Summary

Global next-generation sequencing market is projected to grow at a CAGR of close to 20% to reach USD24 billion during the forecast period. Enhancing regulatory framework for next-generation sequencing based tests for diagnostics is the key factor for the growth of global next-generation sequencing market during the forecast period. Moreover, advancements in next-generation sequencing coupled with reduction in the price of NGS platforms are some other major factors that are anticipated to bolster the growth of global next-generation sequencing market over the coming years. However, some of the factors that might act as major impediments to the growth of global next-generation sequencing market includes concerns pertaining to the standards of NGS based diagnostics.
The global next-generation sequencing market is segmented based on product, technology, end user, application, region and company. Based on technology, the market can be segmented into sequencing by synthesis, ion semiconductor sequencing, sequencing by ligation, pyrosequencing, single molecule real time sequencing and other technologies. Among them, the sequencing by synthesis (SBS) segment dominated the market until 2019 and is projected to grow with a healthy CAGR over the forecast period due to development of new and advanced NGS platforms along with rising demand for Illumina’s systems as it uses the SBS technology.
Major players operating in the global next-generation sequencing market include Illumina, Inc., Thermo Fisher Scientific, Inc, BGI Group, Agilent Technologies, Inc., Qiagen N.V., Hoffmann-La Roche AG, 10x Genomics, Oxford Nanopore Technologies, Takara Bio and others.
Years considered for this report:
Historical Years: 2015-2018
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2021–2025
Objective of the Study:
• To analyse and forecast the market size of global next-generation sequencing market.
• To classify and forecast global next-generation sequencing market based on product, technology, end user, application, company and regional distribution.
• To identify drivers and challenges for global next-generation sequencing market.
• To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global next-generation sequencing market.
• To conduct pricing analysis for global next-generation sequencing market.
• To identify and analyse the profile of leading players operating in global next-generation sequencing market.
TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of service providers across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the service providers which could not be identified due to the limitations of secondary research. TechSci Research analyzed new services, distribution channels and presence of all major players across the globe.
TechSci Research calculated the market size of global next-generation sequencing market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.
Key Target Audience:
• Next-generation sequencing service providers, vendors and other stakeholders
• Government bodies such as regulating authorities and policy makers
• Organizations, forums and alliances related to next-generation sequencing
• Market research and consulting firms
The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as service providers, vendors and partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.
Report Scope:
In this report, global next-generation sequencing market has been segmented into following categories, in addition to the industry trends which have also been detailed below:
• Market, By Product:
o Consumables
o Platforms
o Services
• Market, By Technology:
o Sequencing by Synthesis
o Ion Semiconductor Sequencing
o Sequencing by Ligation
o Pyrosequencing
o Single Molecule Real Time Sequencing
o Other Technologies
• Market, By End User:
o Academic & Clinical Research Centers
o Pharmaceutical & Biotechnology Companies
o Hospitals & Clinics
o Others
• Market, By Application:
o Biomarkers & Cancer
o Diagnostics
o Reproductive Health
o Personalized Medicine
o Agriculture & Animal Research
o Other Applications
• Market, By Region:
o North America
 United States
 Mexico
 Canada
o Europe
 Germany
 France
 United Kingdom
 Italy
 Spain
o Asia-Pacific
 China
 India
 Japan
 South Korea
 Australia
o Middle East & Africa
 South Africa
 UAE
 Saudi Arabia
o South America
 Brazil
 Argentina
 Colombia
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in global next-generation sequencing market.
Available Customizations:
With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:
Company Information
• Detailed analysis and profiling of additional market players (up to five).

ページTOPに戻る

Table of Contents

1. Product Overview
2. Research Methodology
3. Executive Summary
4. Voice of Customer
5. Global Next-generation Sequencing (NGS) Market Outlook
5.1. Market End User & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Product (Consumables, Platforms and Services)
5.2.1.1. By Consumables (Sample preparation consumables and Other Consumables)
5.2.1.2. By Platforms (HiSeq series, MiSeq series, ION Torrent, SOLiD, Pacbio Rs II and Sequel system, Other Sequencing Platforms)
5.2.1.3. By Services (Sequencing Services and Data management services)
5.2.2. By Technology (Sequencing by Synthesis, Ion Semiconductor Sequencing, Sequencing by Ligation, Pyrosequencing, Single Molecule Real Time Sequencing and Other Technologies)
5.2.3. By End User (Academic & Clinical Research Centers, Pharmaceutical & Biotechnology Companies, Hospitals & Clinics and Others)
5.2.4. By Application (Biomarkers & Cancer, Diagnostics, Reproductive Health, Personalized Medicine, Agriculture & Animal Research and Other Applications)
5.2.5. By Region
5.2.6. By Company (2019)
5.2.6.1. By NGS Platform
6. North America Next-generation Sequencing (NGS) Market Outlook
6.1. Market End User & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Product
6.2.2. By Technology
6.2.3. By End User
6.2.4. By Application
6.2.5. By Country (United States; Canada; Mexico and Rest of North America)
6.3. North America: Country Analysis
6.3.1. United States Next-generation Sequencing (NGS) Market Outlook
6.3.1.1. Market End User & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Product
6.3.1.2.2. By Technology
6.3.1.2.3. By Application
6.3.2. Canada Next-generation Sequencing (NGS) Market Outlook
6.3.2.1. Market End User & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Product
6.3.2.2.2. By Technology
6.3.2.2.3. By Application
6.3.3. Mexico Next-generation Sequencing (NGS) Market Outlook
6.3.3.1. Market End User & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Product
6.3.3.2.2. By Technology
6.3.3.2.3. By Application
7. Europe Next-generation Sequencing (NGS) Market Outlook
7.1. Market End User & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Product
7.2.2. By Technology
7.2.3. By End User
7.2.4. By Application
7.2.5. By Country (France; Germany; UK; Italy; Spain and Rest of Europe)
7.3. Europe: Country Analysis
7.3.1. France Next-generation Sequencing (NGS) Market Outlook
7.3.1.1. Market End User & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Product
7.3.1.2.2. By Technology
7.3.1.2.3. By Application
7.3.2. Germany Next-generation Sequencing (NGS) Market Outlook
7.3.2.1. Market End User & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Product
7.3.2.2.2. By Technology
7.3.2.2.3. By Application
7.3.3. United Kingdom Next-generation Sequencing (NGS) Market Outlook
7.3.3.1. Market End User & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Product
7.3.3.2.2. By Technology
7.3.3.2.3. By Application
7.3.4. Italy Next-generation Sequencing (NGS) Market Outlook
7.3.4.1. Market End User & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Product
7.3.4.2.2. By Technology
7.3.4.2.3. By Application
7.3.5. Spain Next-generation Sequencing (NGS) Market Outlook
7.3.5.1. Market End User & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Product
7.3.5.2.2. By Technology
7.3.5.2.3. By Application
8. Asia-Pacific Next-generation Sequencing (NGS) Market Outlook
8.1. Market End User & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Product
8.2.2. By Technology
8.2.3. By End User
8.2.4. By Application
8.2.5. By Country (China; India; Japan; South Korea; Australia; and Rest of Asia Pacific)
8.3. Asia-Pacific: Country Analysis
8.3.1. China Next-generation Sequencing (NGS) Market Outlook
8.3.1.1. Market End User & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Product
8.3.1.2.2. By Technology
8.3.1.2.3. By Application
8.3.2. India Next-generation Sequencing (NGS) Market Outlook
8.3.2.1. Market End User & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Product
8.3.2.2.2. By Technology
8.3.2.2.3. By Application
8.3.3. Japan Next-generation Sequencing (NGS) Market Outlook
8.3.3.1. Market End User & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Product
8.3.3.2.2. By Technology
8.3.3.2.3. By Application
8.3.4. South Korea Next-generation Sequencing (NGS) Market Outlook
8.3.4.1. Market End User & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Product
8.3.4.2.2. By Technology
8.3.4.2.3. By Application
8.3.5. Australia Next-generation Sequencing (NGS) Market Outlook
8.3.5.1. Market End User & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Product
8.3.5.2.2. By Technology
8.3.5.2.3. By Application
9. Middle East and Africa Next-generation Sequencing (NGS) Market Outlook
9.1. Market End User & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Product
9.2.2. By Technology
9.2.3. By End User
9.2.4. By Application
9.2.5. By Country (UAE; Saudi Arabia; South Africa and Rest of Middle East & Africa)
9.3. MEA: Country Analysis
9.3.1. South Africa Next-generation Sequencing (NGS) Market Outlook
9.3.1.1. Market End User & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Product
9.3.1.2.2. By Technology
9.3.1.2.3. By Application
9.3.2. Saudi Arabia Next-generation Sequencing (NGS) Market Outlook
9.3.2.1. Market End User & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Product
9.3.2.2.2. By Technology
9.3.2.2.3. By Application
9.3.3. UAE Next-generation Sequencing (NGS) Market Outlook
9.3.3.1. Market End User & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Product
9.3.3.2.2. By Technology
9.3.3.2.3. By Application
10. South America Next-generation Sequencing (NGS) Market Outlook
10.1. Market End User & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Product
10.2.2. By Technology
10.2.3. By End User
10.2.4. By Application
10.2.5. By Country (Brazil; Argentina; Colombia; and Rest of South America)
10.3. South America: Country Analysis
10.3.1. Brazil Next-generation Sequencing (NGS) Market Outlook
10.3.1.1. Market End User & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Product
10.3.1.2.2. By Technology
10.3.1.2.3. By Application
10.3.2. Argentina Next-generation Sequencing (NGS) Market Outlook
10.3.2.1. Market End User & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Product
10.3.2.2.2. By Technology
10.3.2.2.3. By Application
10.3.3. Colombia Next-generation Sequencing (NGS) Market Outlook
10.3.3.1. Market End User & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Product
10.3.3.2.2. By Technology
10.3.3.2.3. By Application
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
13. Competitive Landscape (NGS Platform Providers)
13.1. Competition Outlook
13.2. Company Profiles
13.2.1. Illumina, Inc.
13.2.2. Thermo Fisher Scientific, Inc
13.2.3. BGI Group
13.2.4. Perkinelmer
13.2.5. Agilent Technologies, Inc.
13.2.6. Qiagen N.V.
13.2.7. F. Hoffmann-La Roche AG
13.2.8. 10x Genomics
13.2.9. Oxford Nanopore Technologies
13.2.10. Takara Bio
14. Strategic Recommendations
15. About Us & Disclaimer
(Note: The companies list can be customized based on the client requirements.)